These 'what if' scenarios are just fantasy and display a lack of understanding of how boards / shareholder rights work. Sorry if that sounded harsh and I don't want to belabor the point, what you're suggesting will never happen in the US.
IP, there is no way GEM could take 100% of the revenue of a sale of Aviptadil like you alluded to earlier. Even in the Sears transaction those funds went to Sears.
Not sure how the company can be sold without considering due interest of all shareholders, not only for the 64%. Beyond me.
Besides, have the board been replaced as of yet? GEM controls only 30.93% of the registered shares. The rest is call option/warrants exercised period 2022/2023 for most part.
Many things can happen, but they have not happened.
Market Data 
Markets 
